Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

Eur Heart J. 2022;43(6):474.

Enlaces

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830527/

Artículos Relacionadas

New therapies for obesity

Postmenopausal Osteoporosis

EMAS position statement: Testosterone replacement therapy in older men

2023: The year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?

A literature review of evidence for primary prevention of overweight and obesity in healthy weight children and adolescents: A report produced by a working group of the Danish Council on Health and Disease Prevention

Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol

The Syndrome of Inappropriate Antidiuresis List of authors.

Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes

European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors

ESPEN guideline on chronic intestinal failure in adults e Update 2023

Agenda

Abril 2024

Lun	Mar	Mié	Jue	Vie	Sáb	Dom
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	1	2	3	4	5

Top